TAS-102 and Oxaliplatin for the Treatment of Refractory Stage IV Colon Cancer
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
This phase II trial studies how well TAS-102 and oxaliplatin work in treating patients with
stage IV colon cancer. Drugs used in chemotherapy, such as TAS-102 and oxaliplatin, work in
different ways to stop the growth of tumor cells, either by killing the cells, by stopping
them from dividing, or by stopping them from spreading.